What Happened?
Boston, MA-based GentiBio Appointed Adel Nada as Co-founder, President and Chief Executive Officer
About the Company
GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases.
About the Person
Adel Nada is Co-founder, President and Chief Executive Officer at GentiBio. Previously, Adel held various senior HR leadership roles in the industry.
Info Source
News
Short Profile